Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancerAlberto Chiappori, Charles Williams, Donald W Northfelt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLungDavid R Spigel, Martin J Edelman, Kenneth O'Byrne, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)Vincent K Lam, Søren M Bentzen, Pranshu Mohindra, et al.
The Annals of Thoracic Surgery|January 28, 2010
Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiationMark J Krasna, Ziv Gamliel, Whitney M Burrows, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group studyQuynh-Thu Le, Jason McCoy, Stephen Williamson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2008
Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgeryTodd W Flannery, Mohan Suntharalingam, William F Regine, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicSameera Kumar, Steven Chmura, Clifford Robinson, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin statusMartin J Edelman, Claus-Peter Schneider, Chun-Ming Tsai, et al.
JCO Precision Oncology|December 14, 2022
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation TherapyJillian A Moran, Daniel L Adams, Martin J Edelman, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancerAlberto Chiappori, Charles Williams, Donald W Northfelt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLungDavid R Spigel, Martin J Edelman, Kenneth O'Byrne, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)Vincent K Lam, Søren M Bentzen, Pranshu Mohindra, et al.
The Annals of Thoracic Surgery|January 28, 2010
Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiationMark J Krasna, Ziv Gamliel, Whitney M Burrows, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group studyQuynh-Thu Le, Jason McCoy, Stephen Williamson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2008
Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgeryTodd W Flannery, Mohan Suntharalingam, William F Regine, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2020
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global PandemicSameera Kumar, Steven Chmura, Clifford Robinson, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin statusMartin J Edelman, Claus-Peter Schneider, Chun-Ming Tsai, et al.
JCO Precision Oncology|December 14, 2022
Monitoring PD-L1 Expression on Circulating Tumor-Associated Cells in Recurrent Metastatic Non-Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation TherapyJillian A Moran, Daniel L Adams, Martin J Edelman, et al.
Pageof 19